Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prashant Tembhare

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Blood Cancer Journal|October 3, 2019
A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1Nikhil Patkar, Anam Fatima Shaikh, Chinmayee Kakirde, et al.
Haematologica|March 25, 2014
A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myelomaNeha Korde, Mattias Carlsten, Min-Jung Lee, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|January 26, 2023
Demographics, Pattern of Care & Outcomes of Primary CNS Lymphoma- Experience from a Tertiary Care Cancer Center in IndiaShasanka Das, Bhausaheb Bagal, Hasmukh Jain, et al.
Cytometry. Part B, Clinical Cytometry|January 10, 2022
Evaluation of multiple myeloma measurable residual disease by high sensitivity flow cytometry: An international harmonized approach for data analysisKah Teong Soh, Neil Came, Gregory E Otteson, et al.
Leukemia & Lymphoma|August 8, 2020
Machine learning derived genomics driven prognostication for acute myeloid leukemia with <i>RUNX1-RUNX1T1</i>Anam Fatima Shaikh, Chinmayee Kakirde, Chetan Dhamne, et al.
Journal of Clinical Pathology|March 12, 2026
Acute myeloid leukaemia (AML) harbouring <i>KMT2A</i>-PTD: should it be considered as a myelodysplasia-related abnormality?Narasimhapriyan Kannan, Aarti Achrekar, Vishram Terse, et al.
Frontiers in Oncology|July 3, 2019
Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia-Real-World ContextNikhil Patkar, Chinmayee Kakirde, Prasanna Bhanshe, et al.
JCO Global Oncology|February 20, 2026
Validation and Refinement of the European LeukemiaNet 2022 Genetic Risk Stratification of AMLGojiri Mawalankar, Aarti Achrekar, Seema Biswas, et al.
International Journal of Clinical Practice|June 10, 2022
Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of MumbaiArusha Shetty, Gaurav Chatterjee, Sweta Rajpal, et al.
Ecancermedicalscience|July 3, 2025
Changing paradigms in pediatric cancer care - the contemporary landscape and perspectives for IndiaBadira Cheriyalinkal Parambil, Nirmalya Roy Moulik, Venkata Rama Mohan Gollamudi, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Blood Cancer Journal|October 3, 2019
A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1Nikhil Patkar, Anam Fatima Shaikh, Chinmayee Kakirde, et al.
Haematologica|March 25, 2014
A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myelomaNeha Korde, Mattias Carlsten, Min-Jung Lee, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|January 26, 2023
Demographics, Pattern of Care & Outcomes of Primary CNS Lymphoma- Experience from a Tertiary Care Cancer Center in IndiaShasanka Das, Bhausaheb Bagal, Hasmukh Jain, et al.
Cytometry. Part B, Clinical Cytometry|January 10, 2022
Evaluation of multiple myeloma measurable residual disease by high sensitivity flow cytometry: An international harmonized approach for data analysisKah Teong Soh, Neil Came, Gregory E Otteson, et al.
Leukemia & Lymphoma|August 8, 2020
Machine learning derived genomics driven prognostication for acute myeloid leukemia with <i>RUNX1-RUNX1T1</i>Anam Fatima Shaikh, Chinmayee Kakirde, Chetan Dhamne, et al.
Journal of Clinical Pathology|March 12, 2026
Acute myeloid leukaemia (AML) harbouring <i>KMT2A</i>-PTD: should it be considered as a myelodysplasia-related abnormality?Narasimhapriyan Kannan, Aarti Achrekar, Vishram Terse, et al.
Frontiers in Oncology|July 3, 2019
Utility of Immunophenotypic Measurable Residual Disease in Adult Acute Myeloid Leukemia-Real-World ContextNikhil Patkar, Chinmayee Kakirde, Prasanna Bhanshe, et al.
JCO Global Oncology|February 20, 2026
Validation and Refinement of the European LeukemiaNet 2022 Genetic Risk Stratification of AMLGojiri Mawalankar, Aarti Achrekar, Seema Biswas, et al.
International Journal of Clinical Practice|June 10, 2022
Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of MumbaiArusha Shetty, Gaurav Chatterjee, Sweta Rajpal, et al.
Ecancermedicalscience|July 3, 2025
Changing paradigms in pediatric cancer care - the contemporary landscape and perspectives for IndiaBadira Cheriyalinkal Parambil, Nirmalya Roy Moulik, Venkata Rama Mohan Gollamudi, et al.
Pageof 9